Who have Somatisation disorder with Inflammation - from FDA reports


Somatisation disorder is reported only by a few people with Inflammation. We study 2 people who have Somatisation disorder and Inflammation from FDA . Find out below who they are, other conditions they have and drugs they take.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Feb, 18, 2019

2 people who have Inflammation and Somatisation Disorder are studied.


Number of reports submitted per year:

Would you have Somatisation disorder when you have Inflammation?

Gender of people who have Inflammation and experience Somatisation Disorder *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Inflammation and experience Somatisation Disorder *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 100 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Top co-existing conditions for these people *:

  1. Quit Smoking: 2 people, 100.00%

Most common drugs for these people *:

  1. Zoloft: 2 people, 100.00%
  2. Zelnorm: 2 people, 100.00%
  3. Albuterol: 2 people, 100.00%
  4. Baclofen: 2 people, 100.00%
  5. Bactrim Ds: 2 people, 100.00%
  6. Celebrex: 2 people, 100.00%
  7. Chantix: 2 people, 100.00%
  8. Claritin: 2 people, 100.00%
  9. Flonase: 2 people, 100.00%
  10. Flovent: 2 people, 100.00%

Top symptoms for these people *:

  1. Sinusitis (inflammation of sinus): 2 people, 100.00%
  2. Rotator Cuff Repair: 2 people, 100.00%
  3. Oedema Peripheral (superficial swelling): 2 people, 100.00%
  4. Hypersensitivity: 2 people, 100.00%
  5. Headache (pain in head): 2 people, 100.00%
  6. Dizziness: 2 people, 100.00%
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.



Do you have Somatisation disorder with Inflammation?

You are not alone:




Related studies


Inflammation

Inflammation can be treated by Prednisone, Ibuprofen, Naproxen, Meloxicam, Celebrex (latest reports from 36,504 Inflammation patients)

Somatisation Disorder

Somatisation disorder (a long-term (chronic) condition in which a person has physical symptoms that involve more than one part of the body) has been reported by people with depression, insomnia, pain, schizophrenia, quit smoking (latest reports from 315 Somatisation disorder patients).


Drugs that are associated with Somatisation disorder
Somatisation disorder (255 drugs)
Other conditions that could cause Somatisation disorder
Somatisation disorder (104 conditions)
Browse all symptoms of Inflammation
a b c d e f g h i j k l m n o p q r s t u v w x y z

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!